RNASEH2B
Basic information
Region (hg38): 13:50909747-51024120
Previous symbols: [ "DLEU8", "AGS2" ]
Links
Phenotypes
GenCC
Source:
- Aicardi-Goutieres syndrome 2 (Definitive), mode of inheritance: AR
- Aicardi-Goutieres syndrome (Supportive), mode of inheritance: AD
- Aicardi-Goutieres syndrome 2 (Definitive), mode of inheritance: AR
- prostate cancer (Limited), mode of inheritance: AD
- Aicardi-Goutieres syndrome 2 (Strong), mode of inheritance: AR
- RNASEH2B-related type 1 interferonopathy (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Aicardi-Goutieres syndrome 2 | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Cardiovascular; Gastrointestinal; Dermatologic; Hematologic; Neurologic | 9706629; 16845400; 20301648; 25243380 |
ClinVar
This is a list of variants' phenotypes submitted to
- Aicardi-Goutieres_syndrome_2 (455 variants)
- not_provided (48 variants)
- Inborn_genetic_diseases (40 variants)
- not_specified (19 variants)
- RNASEH2B-related_disorder (7 variants)
- Aicardi_Goutieres_syndrome (6 variants)
- Hereditary_spastic_paraplegia (2 variants)
- Autism_spectrum_disorder (2 variants)
- Abnormality_of_the_nervous_system (1 variants)
- Cerebral_palsy (1 variants)
- Aicardi-Goutieres_syndrome_1 (1 variants)
- Global_developmental_delay (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNASEH2B gene is commonly pathogenic or not. These statistics are base on transcript: NM_000024570.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 3 | 99 | 1 | 104 | |
| missense | 11 | 141 | 5 | 1 | 158 | |
| nonsense | 8 | 3 | 1 | 12 | ||
| start loss | 1 | 2 | 3 | |||
| frameshift | 11 | 3 | 7 | 1 | 22 | |
| splice donor/acceptor (+/-2bp) | 2 | 16 | 6 | 24 | ||
| Total | 22 | 36 | 158 | 105 | 2 |
Highest pathogenic variant AF is 0.002016424
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| RNASEH2B | protein_coding | protein_coding | ENST00000336617 | 11 | 60779 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125708 | 0 | 40 | 125748 | 0.000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -0.239 | 154 | 146 | 1.06 | 0.00000666 | 2039 |
| Missense in Polyphen | 46 | 43.356 | 1.061 | 644 | ||
| Synonymous | -0.228 | 53 | 50.9 | 1.04 | 0.00000231 | 545 |
| Loss of Function | 0.760 | 15 | 18.5 | 0.810 | 7.76e-7 | 266 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000483 | 0.000483 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.000109 | 0.000109 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000220 | 0.000202 |
| Middle Eastern | 0.000109 | 0.000109 |
| South Asian | 0.000131 | 0.000131 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Non catalytic subunit of RNase H2, an endonuclease that specifically degrades the RNA of RNA:DNA hybrids. Participates in DNA replication, possibly by mediating the removal of lagging- strand Okazaki fragment RNA primers during DNA replication. Mediates the excision of single ribonucleotides from DNA:RNA duplexes. {ECO:0000269|PubMed:16845400, ECO:0000269|PubMed:21177858}.;
- Pathway
- DNA replication - Homo sapiens (human)
(Consensus)
Intolerance Scores
- loftool
- 0.193
- rvis_EVS
- 0.04
- rvis_percentile_EVS
- 56.92
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.275
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- in utero embryonic development;RNA catabolic process;ribonucleotide metabolic process;regulation of G2/M transition of mitotic cell cycle;negative regulation of gene expression;positive regulation of fibroblast proliferation;RNA phosphodiester bond hydrolysis, endonucleolytic;regulation of DNA damage checkpoint
- Cellular component
- nucleus;nucleoplasm;ribonuclease H2 complex
- Molecular function
- RNA-DNA hybrid ribonuclease activity